VGHCX vs. FBTAX

Last updated Jun 24, 2026

VGHCX (Vanguard Health Care Fund Investor Shares) and FBTAX (Fidelity Advisor Biotechnology Fund Class A) are both Health & Biotech Equities funds. Over the past 10 years, VGHCX returned 9.74%/yr vs 13.38%/yr for FBTAX. A 0.76 correlation means they provide meaningful diversification when combined. VGHCX charges 0.33%/yr vs 1.00%/yr for FBTAX.

Performance

VGHCX vs. FBTAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vanguard Health Care Fund Investor Shares (VGHCX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VGHCX achieves a -0.94% return, which is significantly lower than FBTAX's 12.02% return. Over the past 10 years, VGHCX has underperformed FBTAX with an annualized return of 9.74%, while FBTAX has yielded a comparatively higher 13.38% annualized return.

VGHCX

• 1D: 0.93%
• 1M: 0.54%
• YTD: -0.94%
• 6M: -1.48%
• 1Y: 21.58%
• 3Y*: 9.63%
• 5Y*: 6.98%
• 10Y*: 9.74%

FBTAX

• 1D: 5.11%
• 1M: 8.15%
• YTD: 12.02%
• 6M: 9.45%
• 1Y: 64.79%
• 3Y*: 21.95%
• 5Y*: 10.67%
• 10Y*: 13.38%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VGHCX vs. FBTAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VGHCX Vanguard Health Care Fund Investor Shares	-0.94%	19.63%	8.99%	5.46%	-1.05%	14.36%	12.57%	22.93%	1.03%	19.59%
FBTAX Fidelity Advisor Biotechnology Fund Class A	12.02%	39.54%	5.37%	10.70%	-7.95%	-3.10%	32.17%	25.74%	-3.86%	25.80%

Correlation

The correlation between VGHCX and FBTAX is 0.70, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.70
Correlation (3Y) Calculated over the trailing 3-year period	0.72
Correlation (5Y) Calculated over the trailing 5-year period	0.73
Correlation (10Y) Calculated over the trailing 10-year period	0.75
Correlation (All Time) Calculated using the full available price history since Dec 27, 2000	0.76

The correlation between VGHCX and FBTAX has been stable across timeframes, ranging from 0.70 to 0.76 - a consistent structural relationship.

VGHCX vs. FBTAX - Sectors Allocation Comparison

Sectors	VGHCX	FBTAX
Healthcare	98.3%	100.0%
Consumer Defensive	1.2%	-
Financial Services	0.0%	-
Basic Materials	0.0%	-
Communication Services	-	-
Consumer Cyclical	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

VGHCX vs. FBTAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VGHCX

VGHCX Risk / Return Rank: 34
VGHCX Sharpe Ratio Rank: 31
VGHCX Sortino Ratio Rank: 35
VGHCX Omega Ratio Rank: 29
VGHCX Calmar Ratio Rank: 44
VGHCX Martin Ratio Rank: 30

FBTAX

FBTAX Risk / Return Rank: 88
FBTAX Sharpe Ratio Rank: 90
FBTAX Sortino Ratio Rank: 84
FBTAX Omega Ratio Rank: 74
FBTAX Calmar Ratio Rank: 98
FBTAX Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VGHCX vs. FBTAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanguard Health Care Fund Investor Shares (VGHCX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VGHCX	FBTAX	Difference
Sharpe ratio: Return per unit of total volatility	1.49	2.77	-1.28
Sortino ratio: Return per unit of downside risk	2.28	3.68	-1.39
Omega ratio: Gain probability vs. loss probability	1.26	1.44	-0.18
Calmar ratio: Return relative to maximum drawdown	2.42	7.20	-4.78
Martin ratio: Return relative to average drawdown	6.46	19.85	-13.39

VGHCX vs. FBTAX - Sharpe Ratio Comparison

The current VGHCX Sharpe Ratio is 1.49, which is lower than the FBTAX Sharpe Ratio of 2.77. The chart below compares the historical Sharpe Ratios of VGHCX and FBTAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

VGHCX vs. FBTAX - Drawdown Comparison

The maximum VGHCX drawdown since its inception was -36.93%, smaller than the maximum FBTAX drawdown of -63.55%. Use the drawdown chart below to compare losses from any high point for VGHCX and FBTAX.

Drawdown Indicators

	VGHCX	FBTAX	Difference
Max Drawdown Largest peak-to-trough decline	-36.93%	-63.55%	+26.62%
Max Drawdown (1Y) Largest decline over 1 year	-9.20%	-8.91%	-0.29%
Max Drawdown (3Y) Largest decline over 3 years	-16.08%	-32.86%	+16.78%
Max Drawdown (5Y) Largest decline over 5 years	-16.95%	-36.51%	+19.56%
Max Drawdown (10Y) Largest decline over 10 years	-27.18%	-38.82%	+11.64%
Current Drawdown Current decline from peak	-3.99%	0.00%	-3.99%
Average Drawdown Average peak-to-trough decline	-5.24%	-21.18%	+15.94%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.44%	3.23%	+0.21%

Volatility

VGHCX vs. FBTAX - Volatility Comparison

The current volatility for Vanguard Health Care Fund Investor Shares (VGHCX) is 4.74%, while Fidelity Advisor Biotechnology Fund Class A (FBTAX) has a volatility of 9.20%. This indicates that VGHCX experiences smaller price fluctuations and is considered to be less risky than FBTAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VGHCX	FBTAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.74%	9.20%	-4.46%
Volatility (6M) Calculated over the trailing 6-month period	10.65%	18.01%	-7.36%
Volatility (1Y) Calculated over the trailing 1-year period	14.95%	23.20%	-8.25%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.24%	23.69%	-5.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.66%	24.49%	-6.83%

VGHCX vs. FBTAX - Expense Ratio Comparison

VGHCX has a 0.33% expense ratio, which is lower than FBTAX's 1.00% expense ratio.

Dividends

VGHCX vs. FBTAX - Dividend Comparison

VGHCX's dividend yield for the trailing twelve months is around 6.67%, more than FBTAX's 1.30% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FBTAX Fidelity Advisor Biotechnology Fund Class A	1.30%	1.45%	6.00%	1.15%	0.00%	20.12%	8.37%	6.77%	2.50%	0.00%	0.00%	5.36%
VGHCX Vanguard Health Care Fund Investor Shares	6.67%	6.00%	22.72%	7.17%	5.44%	8.31%	7.96%	11.82%	9.10%	7.30%	8.54%	8.16%

Frequently Asked Questions

Can I hold both VGHCX and FBTAX in my portfolio?

VGHCX and FBTAX have a correlation of 0.70, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VGHCX or FBTAX?

FBTAX has higher volatility (9.20%) compared to VGHCX (4.74%). In terms of maximum drawdown, VGHCX dropped -36.93% vs FBTAX's -63.55%.

Which has better risk-adjusted returns?

FBTAX currently has the higher Sharpe Ratio (2.77 vs 1.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.